Lineage Cell Therapeutics In shares owned by Principal Financial Group
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Principal Financial Group
from 13F filings
Historical chart of Principal Financial Group investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Principal Financial Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Principal Financial Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $6.9k | 14k | 0.50 |
| 2024-09-30 | $12k | 14k | 0.91 |
| 2024-06-30 | $19k | 19k | 1.00 |
| 2024-03-31 | $26k | 18k | 1.48 |
| 2023-12-31 | $18k | 16k | 1.09 |
| 2023-09-30 | $18k | 15k | 1.18 |
| 2023-06-30 | $22k | 15k | 1.41 |
| 2022-09-30 | $17k | 15k | 1.14 |
| 2022-06-30 | $65k | 41k | 1.58 |
| 2022-03-31 | $70k | 45k | 1.55 |
| 2021-12-31 | $193k | 79k | 2.45 |
| 2021-09-30 | $313k | 124k | 2.52 |
| 2021-06-30 | $367k | 129k | 2.85 |
| 2020-03-31 | $8.0k | 10k | 0.80 |
| 2019-09-30 | $11k | 11k | 0.96 |